The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

Highlights in Cancer Research: December 2024

October 17, 2025
Highlights in Cancer Research: November 2022

The EACR’s ‘Highlights in Cancer Research’ is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of the European Association for Cancer Research (EACR).

The list below appears in no particular order, and the summary information has been provided by the authors unless otherwise indicated.

Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.

6. Two distinct epithelial-to-mesenchymal transition programs control invasion and inflammation in segregated tumor cell populations

  • 1. Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer
  • 2. Neuronal substance P drives metastasis through an extracellular RNA-TLR7 axis
  • 3. Targeting cancer with small-molecule pan-KRAS degraders
  • 4. Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection
  • 5. Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer
  • 6. Two distinct epithelial-to-mesenchymal transition programs control invasion and inflammation in segregated tumor cell populations
  • 7. ERK5 suppression overcomes FAK inhibitor resistance in mutant KRAS-driven non-small cell lung cancer
  • 8. Macrophage-mediated myelin recycling fuels brain cancer malignancy
  • 9. Single-cell chromatin accessibility reveals malignant regulatory programs in primary human cancers
  • 10. Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
  • 11.
Previous
Next

Youssef, K.K. et al. Nature Cancer. 5: 1660–1680 (2024).
doi: 10.1038/s43018-024-00839-5.

Summary and graphical abstract by Alexandra Boitor, EACR Scientific Officer

Summary of the findings

Epithelial plasticity is known to play a crucial role in cancer progression, but it is also involved in other pathological processes, such as fibrosis and in physiological processes, such as embryonic cell migration and tissue repair. In all these contexts, epithelial plasticity is triggered by epithelial to mesenchymal transition (EMT). In this paper, Youssef et al. investigate EMT in pathological and physiological models and defined two different EMT programmes: an embryonic-like EMT programme and an adult-like EMT programme consistent with wound healing behaviour.
.
Youssef et al. confirm through their experiments that SNAIL1 pioneers EMT induction, being involved in the activation of early mesenchymal genes, and the recruitment of other transcription factors required for EMT progression enhancing the regulation of various epithelial and mesenchymal markers. The authors show that following SNAIL1 activation, PRRX1 is needed for cells to progress from partial EMT to an invasive phenotype through focal adhesion kinase (FAK) signalling (embryonic-like EMT). Following SNAIL1 activation and in the absence of PRRX1 signalling, cells seem to activate a stable, partial EMT with residual cell-cell junctions characterised by dedifferentiation, inflammation and failure to invade (adult-like EMT; wound healing behaviour). Further experiments confirmed that both EMT programmes are hijacked during tumour progression: cells exhibiting characteristics of both EMT programmes can be found within the same tumour (breast cancer) with the inflammatory (partial) EMT cells distributed through the tumour and the invasive EMT cells localised towards the edges of the tumour.
.
.

.Read more in Nature Cancer

6. Two distinct epithelial-to-mesenchymal transition programs control invasion and inflammation in segregated tumor cell populations

  • 1. Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer
  • 2. Neuronal substance P drives metastasis through an extracellular RNA-TLR7 axis
  • 3. Targeting cancer with small-molecule pan-KRAS degraders
  • 4. Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection
  • 5. Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer
  • 6. Two distinct epithelial-to-mesenchymal transition programs control invasion and inflammation in segregated tumor cell populations
  • 7. ERK5 suppression overcomes FAK inhibitor resistance in mutant KRAS-driven non-small cell lung cancer
  • 8. Macrophage-mediated myelin recycling fuels brain cancer malignancy
  • 9. Single-cell chromatin accessibility reveals malignant regulatory programs in primary human cancers
  • 10. Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
  • 11.
Previous
Next
Tags: EACR Top Ten Cancer Research PublicationsHighlights in Cancer Research

Related Posts

VIDEO |  How to get through “failure” in a research career

VIDEO | How to get through “failure” in a research career

October 16, 2025

Click above to watch At the Early Career Researchers’ Conference 2025, we enjoyed a brilliant programme of diverse sessions from a range of experts, including Joan...

Scientific Highlights from Cancer Researchers to Watch: An Early Career Showcase

Scientific Highlights from Cancer Researchers to Watch: An Early Career Showcase

July 16, 2025

Dr. Alexandra Boitor, EACR Scientific Officer, gives a few of the highlights from Cancer Researchers to Watch: An early career showcase (Lisbon, 15-16 June 2025). The EACR's...

Highlights in Cancer Research: November 2022

Highlights in Cancer Research: July 2025

October 17, 2025

The EACR's 'Highlights in Cancer Research' is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

RECENT POSTS

Behind the scenes at the EACR Congress – Episode 26 of The Cancer Researcher Podcast
Podcast

Behind the scenes at the EACR Congress – Episode 26 of The Cancer Researcher Podcast

November 7, 2025
“A combination of professional growth and personal discovery”: Ana Baião’s EACR Travel Fellowship
Community

“A combination of professional growth and personal discovery”: Ana Baião’s EACR Travel Fellowship

November 5, 2025
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

Table of Contents

×
  • 6. Two distinct epithelial-to-mesenchymal transition programs control invasion and inflammation in segregated tumor cell populations
    • Summary of the findings
  • 6. Two distinct epithelial-to-mesenchymal transition programs control invasion and inflammation in segregated tumor cell populations
→ Table of Contents
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR